Deletion of Benitec Biopharma

Comment: The issue is not how the article is written, but whether the company is notable. My impression is that it does not meet . I found a few mentions in minor publications http://www.genomeweb.com/rnai/benitec-track-begin-hcv-trial-13-it-works-raise-investor-interest http://www.thebull.com.au/premium/a/42153-7-biotech-stocks-with-bounding-share-prices.html, but nothing significant. Otherwise just the usual information about the stock price (it is publicly traded, which often gives notability, but it's a penny stock and draws no significant coverage in financial circles
Stance: delete
Cited policy: Wikipedia:Notability (WP:CORP)

Comment: or at least stubify. Much of the information is just completely unnecessary including the speaking tour of the CEO, a list of unexplained patents and details about a bunch of obviously, individually non-notable programs. I'm inclined to agree that the company itself ''might'' pass  but we'd need a machete to hack through the untended backyard that is promo-spam here. The "submission" was "approved" by a single editor, not the broader community. I'm not sure he was necessarily wrong to pass it through AFC but that doesn't mean its existence here cannot be challenged thereafter
Stance: delete
Cited policy: Wikipedia:Notability (WP:CORPDEPTH)